Filing Flows › Integra Lifesciences Holdings (IART) › Guidance history
Integra Lifesciences Holdings (IART) guidance history: what it guided and what it reported
Integra Lifesciences Holdings gave guidance in 2 earnings releases on file since Oct 2, 2026. Its releases raised guidance once and lowered it once.
Revenue
Every guided period is still to be reported.
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| Q4 2026 | $413M–$433M (Oct 21, 2026) | — | to be reported | — |
| FY2026 | $1.6B–$1.7B (Oct 2, 2026) → reaffirmed $1.6B–$1.7B (Oct 21, 2026) | — | to be reported | — |
Operating cash flow
Every guided period is still to be reported.
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| FY2026 | $190M–$200M (Oct 2, 2026) → reaffirmed $190M–$200M (Oct 21, 2026) | — | to be reported | — |
Adjusted EPS
Every guided period is still to be reported.
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| FY2026 | $2.30–$2.40 (Oct 2, 2026) → reaffirmed $2.30–$2.40 (Oct 21, 2026) | — | to be reported | — |
The latest quarter
Integra Lifesciences Holdings, Q3 2026: revenue $411M (+2% year over year), operating margin 4.6%, net earnings $14.9M, operating cash flow $96.0M. The chart follows the revenue to costs, profit and cash.
Questions
Does Integra Lifesciences Holdings beat its guidance?
Integra Lifesciences Holdings gave guidance in 2 earnings releases on file since Oct 2, 2026. Its releases raised guidance once and lowered it once.
How often does Integra Lifesciences Holdings raise guidance?
Its earnings releases raised guidance once and lowered it once since Oct 2, 2026.
Each guided period is held to the last guidance given before its figures were reported; a single figure counts as in line within 1% (0.25 pts for a rate). Reported figures are GAAP, from the company's filings; adjusted guidance shows its moves only.